Ironwood Pharmaceuticals
IRWD
#7068
Rank
โ‚น62.00 B
Marketcap
โ‚น376.66
Share price
-0.26%
Change (1 day)
474.00%
Change (1 year)

Revenue for Ironwood Pharmaceuticals (IRWD)

Revenue in 2026 (TTM): โ‚น32.38 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น34.91 Billion. In 2025 the company made a revenue of โ‚น26.58 Billion a decrease over the revenue in the year 2024 that were of โ‚น30.14 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ironwood Pharmaceuticals from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น32.38 B21.83%
2025 โ‚น26.58 B-11.81%
2024 โ‚น30.14 B-18.21%
2023 โ‚น36.85 B8.48%
2022 โ‚น33.97 B10.33%
2021 โ‚น30.79 B8.1%
2020 โ‚น28.48 B-6.75%
2019 โ‚น30.55 B26.04%
2018 โ‚น24.23 B27.27%
2017 โ‚น19.04 B2.3%
2016 โ‚น18.61 B87.32%
2015 โ‚น9.93 B105.16%
2014 โ‚น4.84 B242.7%
2013 โ‚น1.41 B-82.82%
2012 โ‚น8.22 B136.08%
2011 โ‚น3.48 B77.31%
2010 โ‚น1.96 B18.63%
2009 โ‚น1.65 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AstraZeneca
AZN
โ‚น5.837 T 16,618.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Nektar Therapeutics
NKTR
โ‚น5.37 B-84.61%๐Ÿ‡บ๐Ÿ‡ธ USA